Shares of Stratec SE (ETR:SBS - Get Free Report) fell 2.5% during trading on Monday . The company traded as low as €32.75 ($34.47) and last traded at €33.15 ($34.89). 7,178 shares changed hands during trading, an increase of 15% from the average session volume of 6,253 shares. The stock had previously closed at €34.00 ($35.79).
Stratec Stock Up 0.7 %
The firm has a market cap of $370.02 million, a PE ratio of 36.96, a PEG ratio of 10.43 and a beta of 0.16. The business's 50 day moving average price is €31.91 and its 200 day moving average price is €35.94. The company has a debt-to-equity ratio of 66.97, a current ratio of 2.52 and a quick ratio of 1.65.
Stratec Company Profile
(
Get Free Report)
Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications.
Recommended Stories
Before you consider Stratec, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stratec wasn't on the list.
While Stratec currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
